JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2006, 55(3):115-119

Synthesis of Reactivators of Phosphorylated Acetylcholinesterase of bis-Pyridiniumdialdoxime Type with a 3-Oxapentane Connecting Chain and Their Testing in vitro on a Model of the Enzyme Inhibited by Chlorpyrifos and Methylchlorpyrifos

K. Musílek1, K. Kuča2, D. Jun2, V. Dohnal3, T-H. Kim4, Y.-S. Jung4, M. Doležal1
1 Univerzita Karlova v Praze, Farmaceutická fakulta v Hradci Králové, Katedra farmaceutické chemie a kontroly léčiv
2 Fakulta vojenského zdravotnictví Univerzity obrany Hradec Králové, Katedra toxikologie
3 Mendelova zemědělská a lesnická univerzita Brno, Ústav technologie potravin
4 Medicinal Science Division, Korea Research Institute of Chemical Technology, P. O. Box 107, Yusong, Taejon 05-606, Korea

Insecticides (e. g., parathion, chlorpyrifos, methylchlorpyrifos) and nerve agents (e.g., soman, sarin, tabun, VX) belong to the group of organophosphates. They are able to irreversibly inhibit the enzyme acetylcholinesterase (AChE). Three new reactivators with a 3-oxapentane connecting chain were prepared. The ability of the new compounds to reactivate AChE inhibited by pesticides was tested in vitro and compared to known oximes (pralidoxime, methoxime, trimedoxime, obidoxime, HI-6). The results show that the new substances are superior to known reactivators in the case of methylchlorpyrifos-inhibited AChE at a concentration of 10-3 M which is unfortunately not applicable to in vivo experiments. All tested compounds are practically ineffective for methylchlorpyrifos-inhibited AChE at the physiological concentration (10-5 M). On the other hand, the known reactivators surpass new substances in the case of chlorpyrifos-inhibited AChE at both concentrations.

Keywords: organophosphate; pesticide; acetylcholinesterase; reactivation; in vitro

Received: January 5, 2006; Accepted: February 23, 2006; Published: March 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Musílek K, Kuča K, Jun D, Dohnal V, Kim T, Jung Y-S, Doležal M. Synthesis of Reactivators of Phosphorylated Acetylcholinesterase of bis-Pyridiniumdialdoxime Type with a 3-Oxapentane Connecting Chain and Their Testing in vitro on a Model of the Enzyme Inhibited by Chlorpyrifos and Methylchlorpyrifos. Čes. slov. farm. 2006;55(3):115-119.
Download citation

References

  1. Kuča, K., Cabal, J.: Zprav. Voj. Farm., 2004; XIV, 13-16. Go to original source... Go to PubMed...
  2. Kassa, J.: J. Toxicol. Clin. Toxicol., 2002; 40, 803-816. Go to original source... Go to PubMed...
  3. Ringman, J. M, Cummings, J. L.: Expert. Opin. Investig. Drugs, 1999; 8, 463-471. Go to original source... Go to PubMed...
  4. Sungur, M., Guven, M.: Crit. Care, 2001; 5, 211-215. Go to original source... Go to PubMed...
  5. Fabritius, K., Balasescu, M.: Toxicol. Lett., 1996; 88, 211-214. Go to original source... Go to PubMed...
  6. Marrs, T. C.: Pharmacol. Ther., 1993; 58, 51-66. Go to original source... Go to PubMed...
  7. Kuča, K., Patočka, J., Cabal, J.: J. Appl. Biomed., 2003; 1, 207-211. Go to original source...
  8. Amitai, G., Moorad, D., Adani, R., Doctor, B. P.: Biochem. Pharmacol., 1998; 56, 293-299. Go to original source... Go to PubMed...
  9. Betancourt, A. M., Carr, R. L.: Toxicol. Sci., 2004; 77, 63-71. Go to original source... Go to PubMed...
  10. Taylor, P.: The Pharmacological Basis of Therapeutics. 9th ed. New York, McGraw Hill, 1996, s. 161-176.
  11. Wilson, I. B., Ginsburg, S., Meilisch, E. K.: J. Am. Chem. Soc., 1955; 77, 4286-4291. Go to original source...
  12. Poziomek, E. J., Hackley, B. E., Steinberg, G. M.: J. Org. Chem., 1958; 23, 714-717. Go to original source...
  13. Krejčová, G., Kassa, J.: Toxicology, 2003; 185, 129-139. Go to original source... Go to PubMed...
  14. Kassa, J., Kunešová, G., Vachek, J. et al.: Voj. Zdrav. Listy, 2004; LXXIII, 107-121.
  15. Kuča, K., Bielavský, J., Cabal, J., Bielavská, M.: Tetrahedron Lett., 2003; 44, 3123-3125. Go to original source...
  16. Worek, F., Thiermann, H., Szinicz, L., Eyer, P.: Biochem. Pharmacol.,2004; 68, 2237-2248. Go to original source... Go to PubMed...
  17. Thiermann, H., Szinicz, L., Eyer, F. et al.: Toxicol. Lett., 1999; 107, 233-239. Go to original source... Go to PubMed...
  18. Český Lékopis 2002 - Zkoumadla - Část I. (4.1.1.) - Jodobismutitan draselný RS.
  19. Kim, T.-H., Kuča, K., Jun, D., Jung, Y.-S.: Bioorg. Med. Chem. Lett., 2005; 15, 2914-2917. Go to original source... Go to PubMed...
  20. Kuča, K., Kassa, J.: J. Enzyme Inhib. Med. Chem., 2003; 18, 529-535. Go to original source... Go to PubMed...
  21. Kuča, K., Patočka, J.: J. Enzym. Inhib. Med. Chem., 2004; 19, 39-43. Go to original source... Go to PubMed...
  22. Kuča, K., Cabal, J.: Česk a slov. farm., 2004; LIII, 93-95.
  23. Ševelová, L., Kuča, K., Krejčová, G., Vachek, J.: J. Appl. Biomed., 2004; 2, 163-167. Go to original source...
  24. Cabal, J.; Kuča, K.; Kassa, J.: Pharmacol. Toxicol., 2004; 95, 81-86. Go to original source... Go to PubMed...
  25. Musílek, K., Kuča, K., Jun, D. et al.: Voj. Zdrav. Listy, 2005; 74, 184-185.
  26. Musílek, K., Kuča, K., Jun, D. et al.: J. Enzym. Inhib. Med. Chem., 2005; 20, 409-415.
  27. Musílek, K., Kuča, K., Jun, D. et al.: Bioorg. Med. Chem. Lett., 2006; 16, 622-627.
  28. Musílek, K., Kuča, K., Jun, D. et al.: Zprav. Voj. Farm., 2005; 15, 35-39.




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.